Skip to main content

Advertisement

Fig. 2 | BMC Cancer

Fig. 2

From: Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease

Fig. 2

MiR-19b in HCC is overexpressed in patients with no recurrence (n = 36, median expression level 1.1109, range 0.0192 to 21.104) compared with those whose cancer recurred within 2 years (n = 45, median 0.4988, range 0.1123 to 7.997), P < 0.001, Mann–Whitney test. miR-19b, microRNA-19b. HCC, hepatocellular carcinoma

Back to article page